In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.49.6.2267-2275.2005
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2005
Authors
Publisher
American Society for Microbiology